| Literature DB >> 33808016 |
Veronica Folliero1, Carla Zannella1, Annalisa Chianese1, Debora Stelitano1, Annalisa Ambrosino1, Anna De Filippis2, Marilena Galdiero1, Gianluigi Franci3, Massimiliano Galdiero1.
Abstract
Despite advances in medical knowledge, parasitic diseases remain a significant global health burden and their pharmacological treatment is often hampered by drug toxicity. Therefore, drug delivery systems may provide useful advantages when used in combination with conventional therapeutic compounds. Dendrimers are three-dimensional polymeric structures, characterized by a central core, branches and terminal functional groups. These nanostructures are known for their defined structure, great water solubility, biocompatibility and high encapsulation ability against a wide range of molecules. Furthermore, the high ratio between terminal groups and molecular volume render them a hopeful vector for drug delivery. These nanostructures offer several advantages compared to conventional drugs for the treatment of parasitic infection. Dendrimers deliver drugs to target sites with reduced dosage, solving side effects that occur with accepted marketed drugs. In recent years, extensive progress has been made towards the use of dendrimers for therapeutic, prophylactic and diagnostic purposes for the management of parasitic infections. The present review highlights the potential of several dendrimers in the management of parasitic diseases.Entities:
Keywords: dendrimer; drug delivery; nanostructure; parasite
Year: 2021 PMID: 33808016 PMCID: PMC7998910 DOI: 10.3390/pharmaceutics13030343
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321